Stock 2183 LINICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Linical Co., Ltd.

Equities

2183

JP3974530002

Biotechnology & Medical Research

Delayed Japan Exchange
Other stock markets
 02:29:52 10/05/2024 BST 		5-day change 1st Jan Change
413 JPY -0.24% Intraday chart for Linical Co., Ltd. +0.98% -22.08%
04-12 Linical Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024 CI
02-21 Linical Cuts Revenue, Earnings Forecast on Lower-Than-Expected Sales, Extraordinary Losses MT

Business Summary

Linical Co., Ltd. is a Japan-based company mainly engaged in the contract research organization (CRO) business for drug companies. The Company operates in two businesses. The CRO segment is engaged in the provision of contract monitoring, quality management and consulting services for phase II and phase III in drug development processes. The Pharmaceutical Sales Support segment is engaged in provision of pharmaceutical sales support for medical institutions in the downstream market.

Number of employees: 759

Sales per Business

JPY in Million2022Weight2023Weight Delta
Contract Research Organization
93.2 %
10,615 91.9 % 11,670 93.2 % +9.93%
Drug Development
6.8 %
940 8.1 % 847 6.8 % -9.85%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
45.5 %
5,802 50.2 % 5,701 45.5 % -1.75%
America
31.1 %
2,725 23.6 % 3,895 31.1 % +42.97%
Others
23.3 %
3,028 26.2 % 2,921 23.3 % -3.53%

Managers

Managers TitleAgeSince
Kazuhiro Hatano FOU
 Founder 59 06/06/05
Akihiro Takahashi DFI
 Director of Finance/CFO 56 06/06/05
Shiori Yamaguchi CMP
 Compliance Officer 48 31/05/05
Yoshio Kaji BRD
 Director/Board Member 67 30/09/07
Masaya Miyazaki BRD
 Director/Board Member 52 31/05/06
Jun Kawai BRD
 Director/Board Member 55 30/11/05
Keigo Tsujimoto BRD
 Director/Board Member 60 30/11/07
Isao Sakamoto BRD
 Director/Board Member 48 30/06/05

Members of the board

Members of the board TitleAgeSince
Kazuhiro Hatano FOU
 Founder 59 06/06/05
Akihiro Takahashi DFI
 Director of Finance/CFO 56 06/06/05
Isao Sakamoto BRD
 Director/Board Member 48 30/06/05
Keigo Tsujimoto BRD
 Director/Board Member 60 30/11/07
Jun Kawai BRD
 Director/Board Member 55 30/11/05
Masaya Miyazaki BRD
 Director/Board Member 52 31/05/06
Shiori Yamaguchi CMP
 Compliance Officer 48 31/05/05
Yoshio Kaji BRD
 Director/Board Member 67 30/09/07
Yoshiaki Nakajima BRD
 Director/Board Member - -
Yoshimitsu Ando BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 24,740,000 11,324,436 ( 45.77 %) 2,153,564 ( 8.705 %) 45.77 %

Shareholders

NameEquities%Valuation
Kazuhiro Hatano
21.18 %
5,239,000 21.18 % 14 M ¥
Akihiro Takahashi
11.05 %
2,733,000 11.05 % 7 M ¥
LINICAL CO., LTD.
8.705 %
2,153,500 8.705 % 6 M ¥
Isao Sakamoto
6.237 %
1,543,000 6.237 % 4 M ¥
Keigo Tsujimoto
4.139 %
1,024,000 4.139 % 3 M ¥
Seven Canyons Advisors LLC
3.004 %
743,300 3.004 % 2 M ¥
Koichi Takagi
2.910 %
720,000 2.910 % 2 M ¥
Jun Kawai
2.425 %
600,000 2.425 % 2 M ¥
Masaya Miyazaki
2.425 %
600,000 2.425 % 2 M ¥
Sawakami Asset Management, Inc.
1.409 %
348,700 1.409 % 907 778 ¥

Holdings

NameEquities%Valuation
LINICAL CO., LTD.
8.70%
 2,153,500 8.70% 5,606,250 $

Company contact information

Linical Co., Ltd.

Shin-Osaka Brick Building, 10/F 1-6-1 Miyahara

532-0003, Osaka

+

http://www.linical.co.jp
address Linical Co., Ltd.(2183)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Sales per region

Ratings for Linical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
414 JPY
Average target price
500 JPY
Spread / Average Target
+20.77%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
LINICAL CO., LTD. Stock Linical Co., Ltd.
-22.08% 58.94M
MODERNA, INC. Stock Moderna, Inc.
+23.37% 46.71B
LONZA GROUP AG Stock Lonza Group AG
+48.83% 41.8B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-0.94% 41.52B
CELLTRION, INC. Stock Celltrion, Inc.
-5.86% 29.55B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.29% 25.78B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-20.92% 19.26B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+3.20% 12.14B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-2.67% 12.08B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+30.23% 11.98B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. 2183 Stock
  4. Company Linical Co., Ltd.